Simplex Trading
SYRE icon

Simplex Trading’s Spyre Therapeutics SYRE Stock Holding History

Simplex Trading’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+1,700
New +$124K ﹤0.01% 5070
2026
Q1 		– Sell
-35,300
Closed -$1.16M – 10125
2025
Q4 		$1.16M Buy
+35,300
New +$922K ﹤0.01% 2490
2025
Q3 		– Sell
-300
Closed -$4K – 10048
2025
Q2 		$4K Buy
+300
New +$4.44K ﹤0.01% 7896
2023
Q3 		– Sell
-144
Closed -$1K – 9788
2023
Q2 		$1K Buy
+144
New +$683 ﹤0.01% 8727

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Simplex Trading's SYRE Position: Q2 2026 in Review

Simplex Trading opened a new position in Spyre Therapeutics (SYRE) in Q2 2026: 278 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #6917 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SYRE as recently as Q2 2025.

Simplex Trading first reported a position in SYRE in Q2 2019 and has held it in 16 quarters since. 267 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.

  • Simplex Trading held 278 shares of Spyre Therapeutics worth $24.7K as of Q2 2026.
  • Spyre Therapeutics was a new Simplex Trading position in Q2 2026.
  • Spyre Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6917 holding.
  • Simplex Trading first reported a position in Spyre Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • 267 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.